Drug,Drug Mechanism,Target Gene(s),Drug Constrained Regulon Activity,Drug Constrained Program Activity,All Regulon(s),Overactive Regulon(s),Underactive Regulon(s),All Program(s),Overactive Program(s),Underactive Program(s),Regulon Activity Summary,Program Activity Summary,Mutations,Regulators,MINER Target Type,max_glioblastoma.multiforme_phase,Other FDA Appr.,TargetMutatedInPatient,MutatedInPatient,TargetType,MutatedDetail,Drug Action,Molecule Type,Target Class,Toxicity Class,MEDDRA Code,CHEMBL_ID,Reactome,GO,Hallmarks
CARMUSTINE,RNA inhibitor:DNA inhibitor:Glutathione reductase inhibitor,GSR,1,1,"1663,2320,2679,41,644,681,707","1663,2320,2679,41,644,681,707",NA,101,101,NA,O: 7 U: 0 A: 7,O: 1 U: 0 A: 1,,,Regulon_Gene,4,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR:INHIBITOR:INHIBITOR,Small molecule,Enzyme,,,CHEMBL513,NA:NA:NA:NA:NA,GO_STRESS_GRANULE_ASSEMBLY:GO_REGULATION_OF_CIRCADIAN_RHYTHM:NA:NA:NA,
HYDROXYUREA,Ribonucleoside-diphosphate reductase RR1 inhibitor,RRM2,0.9230769230769231,0,"1030,1720,1818,2051,2292,2529,3637,366,3676,501,693,906,964","1030,1720,1818,2051,2292,3637,366,3676,501,693,906,964",NA,153,NA,NA,O: 12 U: 0 A: 13,O: 0 U: 0 A: 1,,,Regulon_Gene,3,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,Carcinogenicity:Hematological toxicity,10029104.0:10005329.0,CHEMBL467,Cellular Senescence:Oxidative Stress Induced Senescence:RNA Polymerase I Promoter Opening:DNA methylation:Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3,GO_NUCLEOSOME_ASSEMBLY:GO_NUCLEOSOME_ORGANIZATION:GO_CHROMATIN_ASSEMBLY_OR_DISASSEMBLY:GO_DNA_PACKAGING:GO_NEGATIVE_REGULATION_OF_GENE_EXPRESSION_EPIGENETIC,
CAPECITABINE,RNA inhibitor:DNA inhibitor:Thymidylate synthase inhibitor,TYMS,1,0,"941,982","941,982",NA,74,NA,NA,O: 2 U: 0 A: 2,O: 0 U: 0 A: 1,,,Regulon_Gene,2,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR:INHIBITOR:INHIBITOR,Small molecule,Enzyme,,,CHEMBL1773,Unwinding of DNA:DNA strand elongation:G1/S Transition:Mitotic G1 phase and G1/S transition:Synthesis of DNA,GO_CELL_CYCLE_DNA_REPLICATION:GO_CELL_CYCLE_G1_S_PHASE_TRANSITION:GO_DNA_DEPENDENT_DNA_REPLICATION:GO_DNA_REPLICATION:GO_ORGANELLE_FISSION,HALLMARK_E2F_TARGETS:HALLMARK_G2M_CHECKPOINT:HALLMARK_MYC_TARGETS_V1:HALLMARK_MITOTIC_SPINDLE:HALLMARK_MTORC1_SIGNALING
CERITINIB,ALK tyrosine kinase receptor inhibitor,ALK,1,1,"3401,3417","3401,3417",NA,45,45,NA,O: 2 U: 0 A: 2,O: 1 U: 0 A: 1,,,Regulon_Gene,2,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL2403108,RAF/MAP kinase cascade:MAPK1/MAPK3 signaling:FLT3 Signaling:Constitutive Signaling by Aberrant PI3K in Cancer:MAPK family signaling cascades,GO_REGULATION_OF_MAP_KINASE_ACTIVITY:GO_PROTEIN_AUTOPHOSPHORYLATION:NA:NA:NA,
RASAGILINE,Monoamine oxidase B inhibitor,MAOB,1,1,"1437,2971,873","1437,2971,873",NA,89,89,NA,O: 3 U: 0 A: 3,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL887,Passive transport by Aquaporins:Vasopressin regulates renal water homeostasis via Aquaporins:Aquaporin-mediated transport:NA:NA,GO_FLUID_TRANSPORT:NA:NA:NA:NA,
SELEGILINE HYDROCHLORIDE,Monoamine oxidase B inhibitor,MAOB,1,1,"1437,2971,873","1437,2971,873",NA,89,89,NA,O: 3 U: 0 A: 3,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL1200904,Passive transport by Aquaporins:Vasopressin regulates renal water homeostasis via Aquaporins:Aquaporin-mediated transport:NA:NA,GO_FLUID_TRANSPORT:NA:NA:NA:NA,
SELEGILINE,Monoamine oxidase B inhibitor,MAOB,1,1,"1437,2971,873","1437,2971,873",NA,89,89,NA,O: 3 U: 0 A: 3,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,Psychiatric toxicity,10037175,CHEMBL972,Passive transport by Aquaporins:Vasopressin regulates renal water homeostasis via Aquaporins:Aquaporin-mediated transport:NA:NA,GO_FLUID_TRANSPORT:NA:NA:NA:NA,
SAFINAMIDE MESYLATE,Monoamine oxidase B inhibitor,MAOB,1,1,"1437,2971,873","1437,2971,873",NA,89,89,NA,O: 3 U: 0 A: 3,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL48582,Passive transport by Aquaporins:Vasopressin regulates renal water homeostasis via Aquaporins:Aquaporin-mediated transport:NA:NA,GO_FLUID_TRANSPORT:NA:NA:NA:NA,
RASAGILINE MESYLATE,Monoamine oxidase B inhibitor,MAOB,1,1,"1437,2971,873","1437,2971,873",NA,89,89,NA,O: 3 U: 0 A: 3,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL1201142,Passive transport by Aquaporins:Vasopressin regulates renal water homeostasis via Aquaporins:Aquaporin-mediated transport:NA:NA,GO_FLUID_TRANSPORT:NA:NA:NA:NA,
SAFINAMIDE,Monoamine oxidase B inhibitor,MAOB,1,1,"1437,2971,873","1437,2971,873",NA,89,89,NA,O: 3 U: 0 A: 3,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL396778,Passive transport by Aquaporins:Vasopressin regulates renal water homeostasis via Aquaporins:Aquaporin-mediated transport:NA:NA,GO_FLUID_TRANSPORT:NA:NA:NA:NA,
FLOXURIDINE,Thymidylate synthase inhibitor,TYMS,1,0,"941,982","941,982",NA,74,NA,NA,O: 2 U: 0 A: 2,O: 0 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL917,Unwinding of DNA:DNA strand elongation:G1/S Transition:Mitotic G1 phase and G1/S transition:Synthesis of DNA,GO_CELL_CYCLE_DNA_REPLICATION:GO_CELL_CYCLE_G1_S_PHASE_TRANSITION:GO_DNA_DEPENDENT_DNA_REPLICATION:GO_DNA_REPLICATION:GO_ORGANELLE_FISSION,HALLMARK_E2F_TARGETS:HALLMARK_G2M_CHECKPOINT:HALLMARK_MYC_TARGETS_V1:HALLMARK_MITOTIC_SPINDLE:HALLMARK_MTORC1_SIGNALING
RALTITREXED,Thymidylate synthase inhibitor,TYMS,1,0,"941,982","941,982",NA,74,NA,NA,O: 2 U: 0 A: 2,O: 0 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL225071,Unwinding of DNA:DNA strand elongation:G1/S Transition:Mitotic G1 phase and G1/S transition:Synthesis of DNA,GO_CELL_CYCLE_DNA_REPLICATION:GO_CELL_CYCLE_G1_S_PHASE_TRANSITION:GO_DNA_DEPENDENT_DNA_REPLICATION:GO_DNA_REPLICATION:GO_ORGANELLE_FISSION,HALLMARK_E2F_TARGETS:HALLMARK_G2M_CHECKPOINT:HALLMARK_MYC_TARGETS_V1:HALLMARK_MITOTIC_SPINDLE:HALLMARK_MTORC1_SIGNALING
FLUOROURACIL,DNA inhibitor:RNA inhibitor:Thymidylate synthase inhibitor,TYMS,1,0,"941,982","941,982",NA,74,NA,NA,O: 2 U: 0 A: 2,O: 0 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR:INHIBITOR:INHIBITOR,Small molecule,Enzyme,,,CHEMBL185,Unwinding of DNA:DNA strand elongation:G1/S Transition:Mitotic G1 phase and G1/S transition:Synthesis of DNA,GO_CELL_CYCLE_DNA_REPLICATION:GO_CELL_CYCLE_G1_S_PHASE_TRANSITION:GO_DNA_DEPENDENT_DNA_REPLICATION:GO_DNA_REPLICATION:GO_ORGANELLE_FISSION,HALLMARK_E2F_TARGETS:HALLMARK_G2M_CHECKPOINT:HALLMARK_MYC_TARGETS_V1:HALLMARK_MITOTIC_SPINDLE:HALLMARK_MTORC1_SIGNALING
CEP-37440,ALK tyrosine kinase receptor inhibitor:Focal adhesion kinase 1 inhibitor,ALK,1,1,"3401,3417","3401,3417",NA,45,45,NA,O: 2 U: 0 A: 2,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR:INHIBITOR,Small molecule,Enzyme,,,CHEMBL3545051,RAF/MAP kinase cascade:MAPK1/MAPK3 signaling:FLT3 Signaling:Constitutive Signaling by Aberrant PI3K in Cancer:MAPK family signaling cascades,GO_REGULATION_OF_MAP_KINASE_ACTIVITY:GO_PROTEIN_AUTOPHOSPHORYLATION:NA:NA:NA,
LORLATINIB,EML4-ALK  inhibitor:ALK tyrosine kinase receptor inhibitor,ALK,1,1,"3401,3417","3401,3417",NA,45,45,NA,O: 2 U: 0 A: 2,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR:INHIBITOR,Small molecule,Enzyme,,,CHEMBL3286830,RAF/MAP kinase cascade:MAPK1/MAPK3 signaling:FLT3 Signaling:Constitutive Signaling by Aberrant PI3K in Cancer:MAPK family signaling cascades,GO_REGULATION_OF_MAP_KINASE_ACTIVITY:GO_PROTEIN_AUTOPHOSPHORYLATION:NA:NA:NA,
ENSARTINIB,ALK tyrosine kinase receptor inhibitor,ALK,1,1,"3401,3417","3401,3417",NA,45,45,NA,O: 2 U: 0 A: 2,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL4113131,RAF/MAP kinase cascade:MAPK1/MAPK3 signaling:FLT3 Signaling:Constitutive Signaling by Aberrant PI3K in Cancer:MAPK family signaling cascades,GO_REGULATION_OF_MAP_KINASE_ACTIVITY:GO_PROTEIN_AUTOPHOSPHORYLATION:NA:NA:NA,
ASP-3026,ALK tyrosine kinase receptor inhibitor,ALK,1,1,"3401,3417","3401,3417",NA,45,45,NA,O: 2 U: 0 A: 2,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL3545360,RAF/MAP kinase cascade:MAPK1/MAPK3 signaling:FLT3 Signaling:Constitutive Signaling by Aberrant PI3K in Cancer:MAPK family signaling cascades,GO_REGULATION_OF_MAP_KINASE_ACTIVITY:GO_PROTEIN_AUTOPHOSPHORYLATION:NA:NA:NA,
BRIVARACETAM,Synaptic vesicle glycoprotein 2A modulator,SV2A,1,1,"1504,30","1504,30",NA,132,132,NA,O: 2 U: 0 A: 2,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,MODULATOR,Small molecule,Transporter,,,CHEMBL607400,"Neurotransmitter receptors and postsynaptic signal transmission:Neurotoxicity of clostridium toxins:Regulation of glycolysis by fructose 2,6-bisphosphate metabolism:Transmission across Chemical Synapses:CREB1 phosphorylation through the activation of Adenylate Cyclase",NA:NA:NA:NA:NA,
DIMETHYL FUMARATE,Kelch-like ECH-associated protein 1 inhibitor,KEAP1,1,1,"2187,2425,2939,3721","2187,2425,2939,3721",NA,"50,51","50,51",NA,O: 4 U: 0 A: 4,O: 2 U: 0 A: 2,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Unclassified protein,,,CHEMBL2107333,"Dermatan sulfate biosynthesis:CS/DS degradation:Chondroitin sulfate biosynthesis:Defective B4GALT7 causes EDS, progeroid type:Defective B3GAT3 causes JDSSDHD",GO_DERMATAN_SULFATE_METABOLIC_PROCESS:GO_CHONDROITIN_SULFATE_CATABOLIC_PROCESS:GO_DERMATAN_SULFATE_PROTEOGLYCAN_METABOLIC_PROCESS:GO_RNA_SPLICING:GO_POSITIVE_REGULATION_OF_VIRAL_PROCESS,
MONOMETHYL FUMARATE,Kelch-like ECH-associated protein 1 inhibitor,KEAP1,1,1,"2187,2425,2939,3721","2187,2425,2939,3721",NA,"50,51","50,51",NA,O: 4 U: 0 A: 4,O: 2 U: 0 A: 2,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Unclassified protein,,,CHEMBL589586,"Dermatan sulfate biosynthesis:CS/DS degradation:Chondroitin sulfate biosynthesis:Defective B4GALT7 causes EDS, progeroid type:Defective B3GAT3 causes JDSSDHD",GO_DERMATAN_SULFATE_METABOLIC_PROCESS:GO_CHONDROITIN_SULFATE_CATABOLIC_PROCESS:GO_DERMATAN_SULFATE_PROTEOGLYCAN_METABOLIC_PROCESS:GO_RNA_SPLICING:GO_POSITIVE_REGULATION_OF_VIRAL_PROCESS,
DIROXIMEL FUMARATE,Kelch-like ECH-associated protein 1 inhibitor,KEAP1,1,1,"2187,2425,2939,3721","2187,2425,2939,3721",NA,"50,51","50,51",NA,O: 4 U: 0 A: 4,O: 2 U: 0 A: 2,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Unclassified protein,,,CHEMBL3989944,"Dermatan sulfate biosynthesis:CS/DS degradation:Chondroitin sulfate biosynthesis:Defective B4GALT7 causes EDS, progeroid type:Defective B3GAT3 causes JDSSDHD",GO_DERMATAN_SULFATE_METABOLIC_PROCESS:GO_CHONDROITIN_SULFATE_CATABOLIC_PROCESS:GO_DERMATAN_SULFATE_PROTEOGLYCAN_METABOLIC_PROCESS:GO_RNA_SPLICING:GO_POSITIVE_REGULATION_OF_VIRAL_PROCESS,
WARFARIN,Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor,VKORC1,1,1,"1184,3090","1184,3090",NA,152,152,NA,O: 2 U: 0 A: 2,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,Vascular toxicity:Carcinogenicity,10047065.0:10029104.0,CHEMBL1464,Cellular response to hypoxia:Regulation of mRNA stability by proteins that bind AU-rich elements:PCP/CE pathway:Regulation of activated PAK-2p34 by proteasome mediated degradation:Vpu mediated degradation of CD4,GO_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_IN_RESPONSE_TO_HYPOXIA:GO_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_IN_RESPONSE_TO_STRESS:GO_REGULATION_OF_MRNA_CATABOLIC_PROCESS:GO_PROTEASOMAL_UBIQUITIN_INDEPENDENT_PROTEIN_CATABOLIC_PROCESS:GO_CELLULAR_RESPONSE_TO_OXYGEN_LEVELS,HALLMARK_UNFOLDED_PROTEIN_RESPONSE
DICUMAROL,Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor,VKORC1,1,1,"1184,3090","1184,3090",NA,152,152,NA,O: 2 U: 0 A: 2,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL1466,Cellular response to hypoxia:Regulation of mRNA stability by proteins that bind AU-rich elements:PCP/CE pathway:Regulation of activated PAK-2p34 by proteasome mediated degradation:Vpu mediated degradation of CD4,GO_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_IN_RESPONSE_TO_HYPOXIA:GO_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_IN_RESPONSE_TO_STRESS:GO_REGULATION_OF_MRNA_CATABOLIC_PROCESS:GO_PROTEASOMAL_UBIQUITIN_INDEPENDENT_PROTEIN_CATABOLIC_PROCESS:GO_CELLULAR_RESPONSE_TO_OXYGEN_LEVELS,HALLMARK_UNFOLDED_PROTEIN_RESPONSE
PHENINDIONE,Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor,VKORC1,1,1,"1184,3090","1184,3090",NA,152,152,NA,O: 2 U: 0 A: 2,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL711,Cellular response to hypoxia:Regulation of mRNA stability by proteins that bind AU-rich elements:PCP/CE pathway:Regulation of activated PAK-2p34 by proteasome mediated degradation:Vpu mediated degradation of CD4,GO_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_IN_RESPONSE_TO_HYPOXIA:GO_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_IN_RESPONSE_TO_STRESS:GO_REGULATION_OF_MRNA_CATABOLIC_PROCESS:GO_PROTEASOMAL_UBIQUITIN_INDEPENDENT_PROTEIN_CATABOLIC_PROCESS:GO_CELLULAR_RESPONSE_TO_OXYGEN_LEVELS,HALLMARK_UNFOLDED_PROTEIN_RESPONSE
ACENOCOUMAROL,Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor,VKORC1,1,1,"1184,3090","1184,3090",NA,152,152,NA,O: 2 U: 0 A: 2,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL397420,Cellular response to hypoxia:Regulation of mRNA stability by proteins that bind AU-rich elements:PCP/CE pathway:Regulation of activated PAK-2p34 by proteasome mediated degradation:Vpu mediated degradation of CD4,GO_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_IN_RESPONSE_TO_HYPOXIA:GO_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_IN_RESPONSE_TO_STRESS:GO_REGULATION_OF_MRNA_CATABOLIC_PROCESS:GO_PROTEASOMAL_UBIQUITIN_INDEPENDENT_PROTEIN_CATABOLIC_PROCESS:GO_CELLULAR_RESPONSE_TO_OXYGEN_LEVELS,HALLMARK_UNFOLDED_PROTEIN_RESPONSE
PHENPROCOUMON,Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor,VKORC1,1,1,"1184,3090","1184,3090",NA,152,152,NA,O: 2 U: 0 A: 2,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL1465,Cellular response to hypoxia:Regulation of mRNA stability by proteins that bind AU-rich elements:PCP/CE pathway:Regulation of activated PAK-2p34 by proteasome mediated degradation:Vpu mediated degradation of CD4,GO_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_IN_RESPONSE_TO_HYPOXIA:GO_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_IN_RESPONSE_TO_STRESS:GO_REGULATION_OF_MRNA_CATABOLIC_PROCESS:GO_PROTEASOMAL_UBIQUITIN_INDEPENDENT_PROTEIN_CATABOLIC_PROCESS:GO_CELLULAR_RESPONSE_TO_OXYGEN_LEVELS,HALLMARK_UNFOLDED_PROTEIN_RESPONSE
WARFARIN SODIUM,Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor,VKORC1,1,1,"1184,3090","1184,3090",NA,152,152,NA,O: 2 U: 0 A: 2,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,Vascular toxicity:Carcinogenicity,10047065.0:10029104.0,CHEMBL1200879,Cellular response to hypoxia:Regulation of mRNA stability by proteins that bind AU-rich elements:PCP/CE pathway:Regulation of activated PAK-2p34 by proteasome mediated degradation:Vpu mediated degradation of CD4,GO_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_IN_RESPONSE_TO_HYPOXIA:GO_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_IN_RESPONSE_TO_STRESS:GO_REGULATION_OF_MRNA_CATABOLIC_PROCESS:GO_PROTEASOMAL_UBIQUITIN_INDEPENDENT_PROTEIN_CATABOLIC_PROCESS:GO_CELLULAR_RESPONSE_TO_OXYGEN_LEVELS,HALLMARK_UNFOLDED_PROTEIN_RESPONSE
WARFARIN POTASSIUM,Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor,VKORC1,1,1,"1184,3090","1184,3090",NA,152,152,NA,O: 2 U: 0 A: 2,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL1200772,Cellular response to hypoxia:Regulation of mRNA stability by proteins that bind AU-rich elements:PCP/CE pathway:Regulation of activated PAK-2p34 by proteasome mediated degradation:Vpu mediated degradation of CD4,GO_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER_IN_RESPONSE_TO_HYPOXIA:GO_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_IN_RESPONSE_TO_STRESS:GO_REGULATION_OF_MRNA_CATABOLIC_PROCESS:GO_PROTEASOMAL_UBIQUITIN_INDEPENDENT_PROTEIN_CATABOLIC_PROCESS:GO_CELLULAR_RESPONSE_TO_OXYGEN_LEVELS,HALLMARK_UNFOLDED_PROTEIN_RESPONSE
OXIGLUTATIONE,Glutathione reductase,GSR,1,1,"1663,2320,2679,41,644,681,707","1663,2320,2679,41,644,681,707",NA,101,101,NA,O: 7 U: 0 A: 7,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,OTHER,Small molecule,Enzyme,,,CHEMBL1372,NA:NA:NA:NA:NA,GO_STRESS_GRANULE_ASSEMBLY:GO_REGULATION_OF_CIRCADIAN_RHYTHM:NA:NA:NA,
FLUMATINIB,Tyrosine-protein kinase ABL inhibitor,ABL1,1,1,"1011,1034,1092,1152,1180","1011,1034,1092,1152,1180",NA,65,65,NA,O: 5 U: 0 A: 5,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL3545413,Chromatin modifying enzymes:Chromatin organization:RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known:Transcriptional regulation by RUNX1:Transcriptional Regulation by TP53,GO_CHROMATIN_DISASSEMBLY:GO_PROTEIN_DNA_COMPLEX_DISASSEMBLY:GO_COVALENT_CHROMATIN_MODIFICATION:GO_CHROMATIN_REMODELING:GO_PEPTIDYL_LYSINE_MODIFICATION,HALLMARK_MITOTIC_SPINDLE:HALLMARK_G2M_CHECKPOINT
NILOTINIB HYDROCHLORIDE MONOHYDRATE,Tyrosine-protein kinase ABL inhibitor,ABL1,1,1,"1011,1034,1092,1152,1180","1011,1034,1092,1152,1180",NA,65,65,NA,O: 5 U: 0 A: 5,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL1201740,Chromatin modifying enzymes:Chromatin organization:RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known:Transcriptional regulation by RUNX1:Transcriptional Regulation by TP53,GO_CHROMATIN_DISASSEMBLY:GO_PROTEIN_DNA_COMPLEX_DISASSEMBLY:GO_COVALENT_CHROMATIN_MODIFICATION:GO_CHROMATIN_REMODELING:GO_PEPTIDYL_LYSINE_MODIFICATION,HALLMARK_MITOTIC_SPINDLE:HALLMARK_G2M_CHECKPOINT
REBASTINIB,Tyrosine-protein kinase ABL inhibitor,ABL1,1,1,"1011,1034,1092,1152,1180","1011,1034,1092,1152,1180",NA,65,65,NA,O: 5 U: 0 A: 5,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL1738757,Chromatin modifying enzymes:Chromatin organization:RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known:Transcriptional regulation by RUNX1:Transcriptional Regulation by TP53,GO_CHROMATIN_DISASSEMBLY:GO_PROTEIN_DNA_COMPLEX_DISASSEMBLY:GO_COVALENT_CHROMATIN_MODIFICATION:GO_CHROMATIN_REMODELING:GO_PEPTIDYL_LYSINE_MODIFICATION,HALLMARK_MITOTIC_SPINDLE:HALLMARK_G2M_CHECKPOINT
NILOTINIB,Tyrosine-protein kinase ABL inhibitor,ABL1,1,1,"1011,1034,1092,1152,1180","1011,1034,1092,1152,1180",NA,65,65,NA,O: 5 U: 0 A: 5,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,Cardiotoxicity,10007541,CHEMBL255863,Chromatin modifying enzymes:Chromatin organization:RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known:Transcriptional regulation by RUNX1:Transcriptional Regulation by TP53,GO_CHROMATIN_DISASSEMBLY:GO_PROTEIN_DNA_COMPLEX_DISASSEMBLY:GO_COVALENT_CHROMATIN_MODIFICATION:GO_CHROMATIN_REMODELING:GO_PEPTIDYL_LYSINE_MODIFICATION,HALLMARK_MITOTIC_SPINDLE:HALLMARK_G2M_CHECKPOINT
ASCIMINIB,Tyrosine-protein kinase ABL inhibitor,ABL1,1,1,"1011,1034,1092,1152,1180","1011,1034,1092,1152,1180",NA,65,65,NA,O: 5 U: 0 A: 5,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL4208229,Chromatin modifying enzymes:Chromatin organization:RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known:Transcriptional regulation by RUNX1:Transcriptional Regulation by TP53,GO_CHROMATIN_DISASSEMBLY:GO_PROTEIN_DNA_COMPLEX_DISASSEMBLY:GO_COVALENT_CHROMATIN_MODIFICATION:GO_CHROMATIN_REMODELING:GO_PEPTIDYL_LYSINE_MODIFICATION,HALLMARK_MITOTIC_SPINDLE:HALLMARK_G2M_CHECKPOINT
SIMTUZUMAB,Lysyl oxidase homolog 2 inhibitor,LOXL2,1,1,3090,3090,NA,152,152,NA,O: 1 U: 0 A: 1,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Antibody,Enzyme,,,CHEMBL2109667,NA:NA:NA:NA:NA,NA:NA:NA:NA:NA,HALLMARK_UNFOLDED_PROTEIN_RESPONSE
GAVILIMOMAB,Basigin other,BSG,1,1,"1102,934","1102,934",NA,152,152,NA,O: 2 U: 0 A: 2,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,OTHER,Antibody,Membrane receptor,,,CHEMBL2109193,NA:NA:NA:NA:NA,GO_CHAPERONE_MEDIATED_PROTEIN_FOLDING:GO_PROTEIN_INSERTION_INTO_MEMBRANE:GO_REGULATION_OF_PROTEIN_FOLDING:GO_PROTEIN_TARGETING_TO_MITOCHONDRION:GO_PROTEIN_LOCALIZATION_TO_MITOCHONDRION,
ME-344,Mitochondrial complex I (NADH dehydrogenase) inhibitor,NDUFA13,1,1,"865,881,890,902,907","865,881,890,902,907",NA,152,152,NA,O: 5 U: 0 A: 5,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL3545320,"Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.:The citric acid (TCA) cycle and respiratory electron transport:Respiratory electron transport:Complex I biogenesis:Mitochondrial translation initiation",GO_OXIDATIVE_PHOSPHORYLATION:GO_ATP_SYNTHESIS_COUPLED_ELECTRON_TRANSPORT:GO_ATP_METABOLIC_PROCESS:GO_RESPIRATORY_ELECTRON_TRANSPORT_CHAIN:GO_ELECTRON_TRANSPORT_CHAIN,HALLMARK_OXIDATIVE_PHOSPHORYLATION:HALLMARK_DNA_REPAIR:HALLMARK_MYC_TARGETS_V1
FGI-101-1A6,Tumor susceptibility gene 101 protein inhibitor,TSG101,1,1,"881,890","881,890",NA,152,152,NA,O: 2 U: 0 A: 2,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Antibody,Unclassified protein,,,CHEMBL2109593,"Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.:The citric acid (TCA) cycle and respiratory electron transport:Respiratory electron transport:Complex I biogenesis:Mitochondrial translation initiation",GO_OXIDATIVE_PHOSPHORYLATION:GO_ATP_SYNTHESIS_COUPLED_ELECTRON_TRANSPORT:GO_RESPIRATORY_ELECTRON_TRANSPORT_CHAIN:GO_ATP_METABOLIC_PROCESS:GO_ELECTRON_TRANSPORT_CHAIN,HALLMARK_OXIDATIVE_PHOSPHORYLATION:HALLMARK_DNA_REPAIR:HALLMARK_MYC_TARGETS_V1
BRONTICTUZUMAB,Neurogenic locus notch homolog protein 1 inhibitor,NOTCH1,1,1,"1068,1547,2920,2951","1068,1547,2920,2951",NA,50,50,NA,O: 4 U: 0 A: 4,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Antibody,Unclassified protein,,,CHEMBL3545261,Dermatan sulfate biosynthesis:CS/DS degradation:RUNX3 regulates NOTCH signaling:Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells:Chondroitin sulfate biosynthesis,GO_REGULATION_OF_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION:GO_REGULATION_OF_STEM_CELL_DIFFERENTIATION:GO_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION:GO_CARDIOBLAST_PROLIFERATION:GO_PRO_B_CELL_DIFFERENTIATION,HALLMARK_NOTCH_SIGNALING:HALLMARK_WNT_BETA_CATENIN_SIGNALING
VIGABATRIN,Gamma-amino-N-butyrate transaminase inhibitor,ABAT,1,1,"1099,1391,1423,1577,1669,1965,2019,2151,2375,249,2673,3104,3246,334,3469,3692,688","1099,1391,1423,1577,1669,1965,2019,2151,2375,249,2673,3104,3246,334,3469,3692,688",NA,"61,73","61,73",NA,O: 17 U: 0 A: 17,O: 2 U: 0 A: 2,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL89598,Neuronal System:Protein-protein interactions at synapses:Neurexins and neuroligins:NA:NA,NA:NA:NA:NA:NA,
TCD-717,Choline kinase alpha inhibitor,CHKA,1,1,"1527,1664,1737","1527,1664,1737",NA,"52,73","52,73",NA,O: 3 U: 0 A: 3,O: 2 U: 0 A: 2,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL3545084,NA:NA:NA:NA:NA,NA:NA:NA:NA:NA,
VATIQUINONE,Quinone reductase 1) modulator,NQO1,1,1,"2908,521","2908,521",NA,152,152,NA,O: 2 U: 0 A: 2,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,MODULATOR,Small molecule,Enzyme,,,CHEMBL1812161,Regulation of ornithine decarboxylase (ODC):Metabolism of polyamines:G2/M Transition:Mitotic G2-G2/M phases:Cross-presentation of soluble exogenous antigens (endosomes),GO_CELLULAR_RESPONSE_TO_OXYGEN_RADICAL:GO_RESPONSE_TO_OXYGEN_RADICAL:GO_CELL_REDOX_HOMEOSTASIS:GO_REGULATION_OF_CELLULAR_AMINO_ACID_METABOLIC_PROCESS:GO_REGULATION_OF_CELLULAR_AMINE_METABOLIC_PROCESS,HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY
VARESPLADIB,Phospholipase A2 group IIA inhibitor,PLA2G2A,1,1,"2149,2411","2149,2411",NA,12,12,NA,O: 2 U: 0 A: 2,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL148674,Neutrophil degranulation:Glycogen metabolism:Metabolism of carbohydrates:NA:NA,NA:NA:NA:NA:NA,
VONAPANITASE,Elastin proteolytic enzyme,ELN,1,1,1036,1036,NA,89,89,NA,O: 1 U: 0 A: 1,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,PROTEOLYTIC ENZYME,Enzyme,Structural protein,,,CHEMBL3545070,NA:NA:NA:NA:NA,NA:NA:NA:NA:NA,
GSK2798745,Transient receptor potential cation channel subfamily V member 4 antagonist,TRPV4,1,1,3560,3560,NA,71,71,NA,O: 1 U: 0 A: 1,O: 1 U: 0 A: 1,TRPV4,HSF2,Mutation_Gene,NA,TRUE,FALSE,FALSE,Mutation_Gene,,ANTAGONIST,Small molecule,Ion channel,,,CHEMBL3707225,NA:NA:NA:NA:NA,GO_NEURONAL_STEM_CELL_POPULATION_MAINTENANCE:NA:NA:NA:NA,
GALLIUM NITRATE,Ribonucleoside-diphosphate reductase RR1 inhibitor:Hydroxyapatite sequestering agent,RRM2,0.9230769230769231,0,"1030,1720,1818,2051,2292,2529,3637,366,3676,501,693,906,964","1030,1720,1818,2051,2292,3637,366,3676,501,693,906,964",NA,153,NA,NA,O: 12 U: 0 A: 13,O: 0 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR:SEQUESTERING AGENT,Small molecule,Enzyme,,,CHEMBL1200983,Cellular Senescence:Oxidative Stress Induced Senescence:RNA Polymerase I Promoter Opening:DNA methylation:Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3,GO_NUCLEOSOME_ASSEMBLY:GO_NUCLEOSOME_ORGANIZATION:GO_CHROMATIN_ASSEMBLY_OR_DISASSEMBLY:GO_DNA_PACKAGING:GO_NEGATIVE_REGULATION_OF_GENE_EXPRESSION_EPIGENETIC,
TAGRAXOFUSP,Interleukin-3 receptor subunit alpha binding agent:Elongation factor 2 inhibitor,EEF2,0.9090909090909091,1,"1315,2178,2881,3359,3456,3586,3643,386,667,922,929","1315,2178,2881,3359,3456,3586,3643,386,667,922",NA,"50,52,152,157","50,52,152,157",NA,O: 10 U: 0 A: 11,O: 4 U: 0 A: 4,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,BINDING AGENT:INHIBITOR,Protein,Membrane receptor:Other cytosolic protein,Nephrotoxicity,10038359,CHEMBL4297573,NA:NA:NA:NA:NA,GO_POST_EMBRYONIC_ANIMAL_MORPHOGENESIS:GO_POSITIVE_REGULATION_OF_CELL_CYCLE:GO_ANATOMICAL_STRUCTURE_HOMEOSTASIS:GO_REGULATION_OF_CELL_CYCLE_ARREST:GO_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,
MK-8353,MAP kinase ERK1 inhibitor:MAP kinase ERK2 inhibitor,"MAPK1,MAPK3",0.9,0.7,"1164,1194,1507,1531,1633,1672,1694,1776,1903,2018,2047,2218,2417,2705,2803,287,3188,3221,721,756","1164,1194,1507,1531,1633,1672,1694,1776,1903,2018,2047,2218,2705,2803,3188,3221,721,756",NA,"125,126",125,126,O: 18 U: 0 A: 20,O: 1 U: 1 A: 2,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR:INHIBITOR,Small molecule,Enzyme,,,CHEMBL3545001,Intrinsic Pathway for Apoptosis:Signaling by Insulin receptor:PLC beta mediated events:Activation of the AP-1 family of transcription factors:Signal attenuation,GO_REGULATION_OF_PH:GO_ORGANELLE_INHERITANCE:GO_ENDOMEMBRANE_SYSTEM_ORGANIZATION:GO_MONOVALENT_INORGANIC_CATION_HOMEOSTASIS:GO_REGULATION_OF_CELLULAR_PH,
ULIXERTINIB,MAP kinase ERK2 inhibitor:MAP kinase ERK1 inhibitor,"MAPK1,MAPK3",0.9,0.7,"1164,1194,1507,1531,1633,1672,1694,1776,1903,2018,2047,2218,2417,2705,2803,287,3188,3221,721,756","1164,1194,1507,1531,1633,1672,1694,1776,1903,2018,2047,2218,2705,2803,3188,3221,721,756",NA,"125,126",125,126,O: 18 U: 0 A: 20,O: 1 U: 1 A: 2,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR:INHIBITOR,Small molecule,Enzyme,,,CHEMBL3545022,Intrinsic Pathway for Apoptosis:Signaling by Insulin receptor:PLC beta mediated events:Activation of the AP-1 family of transcription factors:Signal attenuation,GO_REGULATION_OF_PH:GO_ORGANELLE_INHERITANCE:GO_ENDOMEMBRANE_SYSTEM_ORGANIZATION:GO_MONOVALENT_INORGANIC_CATION_HOMEOSTASIS:GO_REGULATION_OF_CELLULAR_PH,
RAVOXERTINIB,MAP kinase ERK2 inhibitor:MAP kinase ERK1 inhibitor,"MAPK1,MAPK3",0.9,0.7,"1164,1194,1507,1531,1633,1672,1694,1776,1903,2018,2047,2218,2417,2705,2803,287,3188,3221,721,756","1164,1194,1507,1531,1633,1672,1694,1776,1903,2018,2047,2218,2705,2803,3188,3221,721,756",NA,"125,126",125,126,O: 18 U: 0 A: 20,O: 1 U: 1 A: 2,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR:INHIBITOR,Small molecule,Enzyme,,,CHEMBL3544964,Intrinsic Pathway for Apoptosis:Signaling by Insulin receptor:PLC beta mediated events:Activation of the AP-1 family of transcription factors:Signal attenuation,GO_REGULATION_OF_PH:GO_ORGANELLE_INHERITANCE:GO_ENDOMEMBRANE_SYSTEM_ORGANIZATION:GO_MONOVALENT_INORGANIC_CATION_HOMEOSTASIS:GO_REGULATION_OF_CELLULAR_PH,
FORIGERIMOD,Heat shock cognate 71 kDa protein inhibitor,HSPA8,0.9,1,"1012,1157,1196,1522,1553,1606,1804,2006,215,2183,2198,2208,2233,2240,2241,2265,2279,2304,2325,2370,2393,2404,2704,291,3634,3679,437,461,602,637","1012,1157,1196,1522,1553,1606,1804,2006,215,2183,2198,2208,2233,2279,2304,2325,2370,2393,2404,2704,291,3634,3679,437,461,602,637",NA,"13,90,128","13,90,128",NA,O: 27 U: 0 A: 30,O: 3 U: 0 A: 3,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Protein,Other cytosolic protein,,,CHEMBL3989409,NA:NA:NA:NA:NA,GO_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_ASSEMBLY:GO_GLYCOLIPID_CATABOLIC_PROCESS:GO_CERAMIDE_CATABOLIC_PROCESS:GO_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION:GO_REGULATION_OF_PLATELET_ACTIVATION,
FORIGERIMOD ACETATE,Heat shock cognate 71 kDa protein inhibitor,HSPA8,0.9,1,"1012,1157,1196,1522,1553,1606,1804,2006,215,2183,2198,2208,2233,2240,2241,2265,2279,2304,2325,2370,2393,2404,2704,291,3634,3679,437,461,602,637","1012,1157,1196,1522,1553,1606,1804,2006,215,2183,2198,2208,2233,2279,2304,2325,2370,2393,2404,2704,291,3634,3679,437,461,602,637",NA,"13,90,128","13,90,128",NA,O: 27 U: 0 A: 30,O: 3 U: 0 A: 3,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Protein,Other cytosolic protein,,,CHEMBL3989801,NA:NA:NA:NA:NA,GO_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_ASSEMBLY:GO_GLYCOLIPID_CATABOLIC_PROCESS:GO_CERAMIDE_CATABOLIC_PROCESS:GO_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION:GO_REGULATION_OF_PLATELET_ACTIVATION,
DIGITOXIN,Sodium/potassium-transporting ATPase inhibitor,ATP1A1,0.88,0.6533333333333333,"100,1015,105,1050,1093,11,1137,1159,1218,1418,1420,1526,1557,157,1641,1732,1755,1759,179,1829,1847,1898,1987,2040,206,2210,2213,223,2282,2285,2327,2334,236,2407,2617,2630,2680,2684,2700,2730,2759,2768,2821,2871,2903,3021,3070,3128,3161,3199,3253,3272,3460,3467,36,3677,379,381,382,39,441,45,465,483,488,539,559,576,599,680,686,704,718,768,815","100,1015,105,1050,1137,1159,1218,1418,1420,1526,1557,157,1641,1732,1755,179,1829,1847,1898,1987,2040,2213,223,2282,2327,2334,236,2407,2617,2630,2680,2684,2700,2730,2759,2768,2821,2871,2903,3021,3070,3128,3161,3199,3253,3272,3460,379,381,382,39,441,45,465,483,488,539,559,576,599,680,686,704,718,768,815",NA,"1,8,11,13,14,17,21","1,11,13",NA,O: 66 U: 0 A: 75,O: 3 U: 0 A: 7,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL254219,Extracellular matrix organization:ECM proteoglycans:Laminin interactions:MET activates PTK2 signaling:SARS-CoV Infections,GO_CELL_SUBSTRATE_ADHESION:GO_CELL_MATRIX_ADHESION:GO_EXTRACELLULAR_STRUCTURE_ORGANIZATION:GO_POSITIVE_REGULATION_OF_CELL_MATRIX_ADHESION:GO_REGULATION_OF_CELL_MATRIX_ADHESION,HALLMARK_TNFA_SIGNALING_VIA_NFKB:HALLMARK_UV_RESPONSE_DN:HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION:HALLMARK_TGF_BETA_SIGNALING
DESLANOSIDE,Sodium/potassium-transporting ATPase inhibitor,ATP1A1,0.88,0.6533333333333333,"100,1015,105,1050,1093,11,1137,1159,1218,1418,1420,1526,1557,157,1641,1732,1755,1759,179,1829,1847,1898,1987,2040,206,2210,2213,223,2282,2285,2327,2334,236,2407,2617,2630,2680,2684,2700,2730,2759,2768,2821,2871,2903,3021,3070,3128,3161,3199,3253,3272,3460,3467,36,3677,379,381,382,39,441,45,465,483,488,539,559,576,599,680,686,704,718,768,815","100,1015,105,1050,1137,1159,1218,1418,1420,1526,1557,157,1641,1732,1755,179,1829,1847,1898,1987,2040,2213,223,2282,2327,2334,236,2407,2617,2630,2680,2684,2700,2730,2759,2768,2821,2871,2903,3021,3070,3128,3161,3199,3253,3272,3460,379,381,382,39,441,45,465,483,488,539,559,576,599,680,686,704,718,768,815",NA,"1,8,11,13,14,17,21","1,11,13",NA,O: 66 U: 0 A: 75,O: 3 U: 0 A: 7,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL1614,Extracellular matrix organization:ECM proteoglycans:Laminin interactions:MET activates PTK2 signaling:SARS-CoV Infections,GO_CELL_SUBSTRATE_ADHESION:GO_CELL_MATRIX_ADHESION:GO_EXTRACELLULAR_STRUCTURE_ORGANIZATION:GO_POSITIVE_REGULATION_OF_CELL_MATRIX_ADHESION:GO_REGULATION_OF_CELL_MATRIX_ADHESION,HALLMARK_TNFA_SIGNALING_VIA_NFKB:HALLMARK_UV_RESPONSE_DN:HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION:HALLMARK_TGF_BETA_SIGNALING
DIGOXIN,Sodium/potassium-transporting ATPase inhibitor,ATP1A1,0.88,0.6533333333333333,"100,1015,105,1050,1093,11,1137,1159,1218,1418,1420,1526,1557,157,1641,1732,1755,1759,179,1829,1847,1898,1987,2040,206,2210,2213,223,2282,2285,2327,2334,236,2407,2617,2630,2680,2684,2700,2730,2759,2768,2821,2871,2903,3021,3070,3128,3161,3199,3253,3272,3460,3467,36,3677,379,381,382,39,441,45,465,483,488,539,559,576,599,680,686,704,718,768,815","100,1015,105,1050,1137,1159,1218,1418,1420,1526,1557,157,1641,1732,1755,179,1829,1847,1898,1987,2040,2213,223,2282,2327,2334,236,2407,2617,2630,2680,2684,2700,2730,2759,2768,2821,2871,2903,3021,3070,3128,3161,3199,3253,3272,3460,379,381,382,39,441,45,465,483,488,539,559,576,599,680,686,704,718,768,815",NA,"1,8,11,13,14,17,21","1,11,13",NA,O: 66 U: 0 A: 75,O: 3 U: 0 A: 7,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL1751,Extracellular matrix organization:ECM proteoglycans:Laminin interactions:MET activates PTK2 signaling:SARS-CoV Infections,GO_CELL_SUBSTRATE_ADHESION:GO_CELL_MATRIX_ADHESION:GO_EXTRACELLULAR_STRUCTURE_ORGANIZATION:GO_POSITIVE_REGULATION_OF_CELL_MATRIX_ADHESION:GO_REGULATION_OF_CELL_MATRIX_ADHESION,HALLMARK_TNFA_SIGNALING_VIA_NFKB:HALLMARK_UV_RESPONSE_DN:HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION:HALLMARK_TGF_BETA_SIGNALING
ACETYLDIGITOXIN,Sodium/potassium-transporting ATPase inhibitor,ATP1A1,0.88,0.6533333333333333,"100,1015,105,1050,1093,11,1137,1159,1218,1418,1420,1526,1557,157,1641,1732,1755,1759,179,1829,1847,1898,1987,2040,206,2210,2213,223,2282,2285,2327,2334,236,2407,2617,2630,2680,2684,2700,2730,2759,2768,2821,2871,2903,3021,3070,3128,3161,3199,3253,3272,3460,3467,36,3677,379,381,382,39,441,45,465,483,488,539,559,576,599,680,686,704,718,768,815","100,1015,105,1050,1137,1159,1218,1418,1420,1526,1557,157,1641,1732,1755,179,1829,1847,1898,1987,2040,2213,223,2282,2327,2334,236,2407,2617,2630,2680,2684,2700,2730,2759,2768,2821,2871,2903,3021,3070,3128,3161,3199,3253,3272,3460,379,381,382,39,441,45,465,483,488,539,559,576,599,680,686,704,718,768,815",NA,"1,8,11,13,14,17,21","1,11,13",NA,O: 66 U: 0 A: 75,O: 3 U: 0 A: 7,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL3545057,Extracellular matrix organization:ECM proteoglycans:Laminin interactions:MET activates PTK2 signaling:SARS-CoV Infections,GO_CELL_SUBSTRATE_ADHESION:GO_CELL_MATRIX_ADHESION:GO_EXTRACELLULAR_STRUCTURE_ORGANIZATION:GO_POSITIVE_REGULATION_OF_CELL_MATRIX_ADHESION:GO_REGULATION_OF_CELL_MATRIX_ADHESION,HALLMARK_TNFA_SIGNALING_VIA_NFKB:HALLMARK_UV_RESPONSE_DN:HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION:HALLMARK_TGF_BETA_SIGNALING
VARESPLADIB METHYL,Phospholipase A2 group V inhibitor:Group X secretory phospholipase A2 inhibitor:Phospholipase A2 group IIA inhibitor,"PLA2G2A,PLA2G5",0.875,1,"1359,1415,1959,1983,2031,2106,2149,2411","1359,1959,1983,2031,2106,2149,2411",NA,"12,48,91","12,48,91",NA,O: 7 U: 0 A: 8,O: 3 U: 0 A: 3,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR:INHIBITOR:INHIBITOR,Small molecule,Enzyme,,,CHEMBL2105659,NA:NA:NA:NA:NA,NA:NA:NA:NA:NA,HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION:HALLMARK_TNFA_SIGNALING_VIA_NFKB
BITOPERTIN,Glycine transporter 1 inhibitor,SLC6A9,0.8666666666666667,1,"1160,1329,1347,1471,1632,1668,2429,2433,2590,3025,3057,3331,3455,3656,3719","1160,1329,1347,1632,1668,2429,2433,3025,3057,3331,3455,3656,3719",NA,"46,89,162","46,89,162",NA,O: 13 U: 0 A: 15,O: 3 U: 0 A: 3,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Transporter,,,CHEMBL1171829,NA:NA:NA:NA:NA,NA:NA:NA:NA:NA,
PONEZUMAB,Beta amyloid A4 protein binding agent,APP,0.8536585365853658,0.975609756097561,"1130,1144,1349,1399,1534,1656,1775,1835,186,1968,2025,2050,2081,2152,2226,2247,2293,2421,2522,2564,2611,2687,2709,2742,2975,3031,3096,3163,3386,3395,3434,3713,449,499,522,56,584,691,723,773,78","1130,1144,1349,1399,1534,1656,1775,1835,1968,2025,2050,2081,2152,2226,2247,2293,2421,2522,2687,2709,2742,2975,3031,3163,3386,3713,449,499,522,56,584,691,723,773,78",NA,"10,43,47","10,43",NA,O: 35 U: 0 A: 41,O: 2 U: 0 A: 3,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,BINDING AGENT,Antibody,Membrane receptor,,,CHEMBL1743058,NA:NA:NA:NA:NA,GO_CELLULAR_RESPONSE_TO_NUTRIENT:GO_CELLULAR_RESPONSE_TO_EXTRACELLULAR_STIMULUS:GO_LIPID_LOCALIZATION:GO_CELLULAR_RESPONSE_TO_EXTERNAL_STIMULUS:GO_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,HALLMARK_ANGIOGENESIS:HALLMARK_TNFA_SIGNALING_VIA_NFKB
GSK933776,Beta amyloid A4 protein binding agent,APP,0.8536585365853658,0.975609756097561,"1130,1144,1349,1399,1534,1656,1775,1835,186,1968,2025,2050,2081,2152,2226,2247,2293,2421,2522,2564,2611,2687,2709,2742,2975,3031,3096,3163,3386,3395,3434,3713,449,499,522,56,584,691,723,773,78","1130,1144,1349,1399,1534,1656,1775,1835,1968,2025,2050,2081,2152,2226,2247,2293,2421,2522,2687,2709,2742,2975,3031,3163,3386,3713,449,499,522,56,584,691,723,773,78",NA,"10,43,47","10,43",NA,O: 35 U: 0 A: 41,O: 2 U: 0 A: 3,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,BINDING AGENT,Antibody,Membrane receptor,,,CHEMBL2109300,NA:NA:NA:NA:NA,GO_CELLULAR_RESPONSE_TO_NUTRIENT:GO_CELLULAR_RESPONSE_TO_EXTRACELLULAR_STIMULUS:GO_LIPID_LOCALIZATION:GO_CELLULAR_RESPONSE_TO_EXTERNAL_STIMULUS:GO_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,HALLMARK_ANGIOGENESIS:HALLMARK_TNFA_SIGNALING_VIA_NFKB
BAPINEUZUMAB,Beta amyloid A4 protein binding agent,APP,0.8536585365853658,0.975609756097561,"1130,1144,1349,1399,1534,1656,1775,1835,186,1968,2025,2050,2081,2152,2226,2247,2293,2421,2522,2564,2611,2687,2709,2742,2975,3031,3096,3163,3386,3395,3434,3713,449,499,522,56,584,691,723,773,78","1130,1144,1349,1399,1534,1656,1775,1835,1968,2025,2050,2081,2152,2226,2247,2293,2421,2522,2687,2709,2742,2975,3031,3163,3386,3713,449,499,522,56,584,691,723,773,78",NA,"10,43,47","10,43",NA,O: 35 U: 0 A: 41,O: 2 U: 0 A: 3,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,BINDING AGENT,Antibody,Membrane receptor,,,CHEMBL2108576,NA:NA:NA:NA:NA,GO_CELLULAR_RESPONSE_TO_NUTRIENT:GO_CELLULAR_RESPONSE_TO_EXTRACELLULAR_STIMULUS:GO_LIPID_LOCALIZATION:GO_CELLULAR_RESPONSE_TO_EXTERNAL_STIMULUS:GO_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,HALLMARK_ANGIOGENESIS:HALLMARK_TNFA_SIGNALING_VIA_NFKB
GANTENERUMAB,Beta amyloid A4 protein binding agent,APP,0.8536585365853658,0.975609756097561,"1130,1144,1349,1399,1534,1656,1775,1835,186,1968,2025,2050,2081,2152,2226,2247,2293,2421,2522,2564,2611,2687,2709,2742,2975,3031,3096,3163,3386,3395,3434,3713,449,499,522,56,584,691,723,773,78","1130,1144,1349,1399,1534,1656,1775,1835,1968,2025,2050,2081,2152,2226,2247,2293,2421,2522,2687,2709,2742,2975,3031,3163,3386,3713,449,499,522,56,584,691,723,773,78",NA,"10,43,47","10,43",NA,O: 35 U: 0 A: 41,O: 2 U: 0 A: 3,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,BINDING AGENT,Antibody,Membrane receptor,,,CHEMBL1743025,NA:NA:NA:NA:NA,GO_CELLULAR_RESPONSE_TO_NUTRIENT:GO_CELLULAR_RESPONSE_TO_EXTRACELLULAR_STIMULUS:GO_LIPID_LOCALIZATION:GO_CELLULAR_RESPONSE_TO_EXTERNAL_STIMULUS:GO_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,HALLMARK_ANGIOGENESIS:HALLMARK_TNFA_SIGNALING_VIA_NFKB
SOLANEZUMAB,Beta amyloid A4 protein binding agent,APP,0.8536585365853658,0.975609756097561,"1130,1144,1349,1399,1534,1656,1775,1835,186,1968,2025,2050,2081,2152,2226,2247,2293,2421,2522,2564,2611,2687,2709,2742,2975,3031,3096,3163,3386,3395,3434,3713,449,499,522,56,584,691,723,773,78","1130,1144,1349,1399,1534,1656,1775,1835,1968,2025,2050,2081,2152,2226,2247,2293,2421,2522,2687,2709,2742,2975,3031,3163,3386,3713,449,499,522,56,584,691,723,773,78",NA,"10,43,47","10,43",NA,O: 35 U: 0 A: 41,O: 2 U: 0 A: 3,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,BINDING AGENT,Antibody,Membrane receptor,,,CHEMBL1743072,NA:NA:NA:NA:NA,GO_CELLULAR_RESPONSE_TO_NUTRIENT:GO_CELLULAR_RESPONSE_TO_EXTRACELLULAR_STIMULUS:GO_LIPID_LOCALIZATION:GO_CELLULAR_RESPONSE_TO_EXTERNAL_STIMULUS:GO_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,HALLMARK_ANGIOGENESIS:HALLMARK_TNFA_SIGNALING_VIA_NFKB
ADUCANUMAB,Beta amyloid A4 protein binding agent,APP,0.8536585365853658,0.975609756097561,"1130,1144,1349,1399,1534,1656,1775,1835,186,1968,2025,2050,2081,2152,2226,2247,2293,2421,2522,2564,2611,2687,2709,2742,2975,3031,3096,3163,3386,3395,3434,3713,449,499,522,56,584,691,723,773,78","1130,1144,1349,1399,1534,1656,1775,1835,1968,2025,2050,2081,2152,2226,2247,2293,2421,2522,2687,2709,2742,2975,3031,3163,3386,3713,449,499,522,56,584,691,723,773,78",NA,"10,43,47","10,43",NA,O: 35 U: 0 A: 41,O: 2 U: 0 A: 3,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,BINDING AGENT,Antibody,Membrane receptor,,,CHEMBL3039540,NA:NA:NA:NA:NA,GO_CELLULAR_RESPONSE_TO_NUTRIENT:GO_CELLULAR_RESPONSE_TO_EXTRACELLULAR_STIMULUS:GO_LIPID_LOCALIZATION:GO_CELLULAR_RESPONSE_TO_EXTERNAL_STIMULUS:GO_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,HALLMARK_ANGIOGENESIS:HALLMARK_TNFA_SIGNALING_VIA_NFKB
LECANEMAB,Beta amyloid A4 protein inhibitor,APP,0.8536585365853658,0.975609756097561,"1130,1144,1349,1399,1534,1656,1775,1835,186,1968,2025,2050,2081,2152,2226,2247,2293,2421,2522,2564,2611,2687,2709,2742,2975,3031,3096,3163,3386,3395,3434,3713,449,499,522,56,584,691,723,773,78","1130,1144,1349,1399,1534,1656,1775,1835,1968,2025,2050,2081,2152,2226,2247,2293,2421,2522,2687,2709,2742,2975,3031,3163,3386,3713,449,499,522,56,584,691,723,773,78",NA,"10,43,47","10,43",NA,O: 35 U: 0 A: 41,O: 2 U: 0 A: 3,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Antibody,Membrane receptor,,,CHEMBL3833321,NA:NA:NA:NA:NA,GO_CELLULAR_RESPONSE_TO_NUTRIENT:GO_CELLULAR_RESPONSE_TO_EXTRACELLULAR_STIMULUS:GO_LIPID_LOCALIZATION:GO_CELLULAR_RESPONSE_TO_EXTERNAL_STIMULUS:GO_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,HALLMARK_ANGIOGENESIS:HALLMARK_TNFA_SIGNALING_VIA_NFKB
CRENEZUMAB,Beta amyloid A4 protein inhibitor,APP,0.8536585365853658,0.975609756097561,"1130,1144,1349,1399,1534,1656,1775,1835,186,1968,2025,2050,2081,2152,2226,2247,2293,2421,2522,2564,2611,2687,2709,2742,2975,3031,3096,3163,3386,3395,3434,3713,449,499,522,56,584,691,723,773,78","1130,1144,1349,1399,1534,1656,1775,1835,1968,2025,2050,2081,2152,2226,2247,2293,2421,2522,2687,2709,2742,2975,3031,3163,3386,3713,449,499,522,56,584,691,723,773,78",NA,"10,43,47","10,43",NA,O: 35 U: 0 A: 41,O: 2 U: 0 A: 3,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Antibody,Membrane receptor,,,CHEMBL1743004,NA:NA:NA:NA:NA,GO_CELLULAR_RESPONSE_TO_NUTRIENT:GO_CELLULAR_RESPONSE_TO_EXTRACELLULAR_STIMULUS:GO_LIPID_LOCALIZATION:GO_CELLULAR_RESPONSE_TO_EXTERNAL_STIMULUS:GO_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,HALLMARK_ANGIOGENESIS:HALLMARK_TNFA_SIGNALING_VIA_NFKB
TOFERSEN,SOD1 mRNA inhibitor,SOD1,0.8333333333333334,1,"1252,1661,1828,2008,3069,552","1661,1828,2008,3069,552",NA,"128,137","128,137",NA,O: 5 U: 0 A: 6,O: 2 U: 0 A: 2,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Oligonucleotide,Enzyme,,,CHEMBL3833346,NA:NA:NA:NA:NA,GO_CELLULAR_IRON_ION_HOMEOSTASIS:GO_IRON_ION_HOMEOSTASIS:GO_CELLULAR_TRANSITION_METAL_ION_HOMEOSTASIS:GO_TRANSITION_METAL_ION_HOMEOSTASIS:GO_CELLULAR_RESPONSE_TO_NITROGEN_STARVATION,HALLMARK_OXIDATIVE_PHOSPHORYLATION:HALLMARK_ADIPOGENESIS
BIMAGRUMAB,Activin receptor type-2B antagonist,ACVR2B,0.8333333333333334,0.8333333333333334,"1011,1092,1112,1152,1568,987","1011,1092,1112,1152,987",NA,"65,66",65,NA,O: 5 U: 0 A: 6,O: 1 U: 0 A: 2,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,ANTAGONIST,Antibody,Enzyme,,,CHEMBL3137353,Chromatin modifying enzymes:Chromatin organization:RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known:Transcriptional regulation by RUNX1:Transcriptional Regulation by TP53,GO_COVALENT_CHROMATIN_MODIFICATION:GO_CHROMATIN_DISASSEMBLY:GO_PROTEIN_DNA_COMPLEX_DISASSEMBLY:GO_PEPTIDYL_LYSINE_MODIFICATION:GO_CHROMATIN_REMODELING,HALLMARK_MITOTIC_SPINDLE:HALLMARK_G2M_CHECKPOINT
BARUSIBAN,Oxytocin receptor antagonist,OXTR,0.8181818181818182,1,"1359,1939,1959,2031,2055,2093,2142,2146,405,439,837","1359,1939,1959,2031,2055,2093,2146,439,837",NA,"48,91","48,91",NA,O: 9 U: 0 A: 11,O: 2 U: 0 A: 2,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,ANTAGONIST,Protein,Membrane receptor,,,CHEMBL2218898,NA:NA:NA:NA:NA,NA:NA:NA:NA:NA,
EPELSIBAN,Oxytocin receptor antagonist,OXTR,0.8181818181818182,1,"1359,1939,1959,2031,2055,2093,2142,2146,405,439,837","1359,1939,1959,2031,2055,2093,2146,439,837",NA,"48,91","48,91",NA,O: 9 U: 0 A: 11,O: 2 U: 0 A: 2,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,ANTAGONIST,Small molecule,Membrane receptor,,,CHEMBL2037511,NA:NA:NA:NA:NA,NA:NA:NA:NA:NA,
RETOSIBAN,Oxytocin receptor antagonist,OXTR,0.8181818181818182,1,"1359,1939,1959,2031,2055,2093,2142,2146,405,439,837","1359,1939,1959,2031,2055,2093,2146,439,837",NA,"48,91","48,91",NA,O: 9 U: 0 A: 11,O: 2 U: 0 A: 2,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,ANTAGONIST,Small molecule,Membrane receptor,,,CHEMBL429736,NA:NA:NA:NA:NA,NA:NA:NA:NA:NA,
OXYTOCIN,Oxytocin receptor agonist,OXTR,0.8181818181818182,1,"1359,1939,1959,2031,2055,2093,2142,2146,405,439,837","1359,1939,1959,2031,2055,2093,2146,439,837",NA,"48,91","48,91",NA,O: 9 U: 0 A: 11,O: 2 U: 0 A: 2,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,AGONIST,Protein,Membrane receptor,,,CHEMBL395429,NA:NA:NA:NA:NA,NA:NA:NA:NA:NA,
CARBETOCIN,Oxytocin receptor agonist,OXTR,0.8181818181818182,1,"1359,1939,1959,2031,2055,2093,2142,2146,405,439,837","1359,1939,1959,2031,2055,2093,2146,439,837",NA,"48,91","48,91",NA,O: 9 U: 0 A: 11,O: 2 U: 0 A: 2,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,AGONIST,Protein,Membrane receptor,,,CHEMBL3301668,NA:NA:NA:NA:NA,NA:NA:NA:NA:NA,
FE 202767,Oxytocin receptor agonist,OXTR,0.8181818181818182,1,"1359,1939,1959,2031,2055,2093,2142,2146,405,439,837","1359,1939,1959,2031,2055,2093,2146,439,837",NA,"48,91","48,91",NA,O: 9 U: 0 A: 11,O: 2 U: 0 A: 2,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,AGONIST,Protein,Membrane receptor,,,CHEMBL3545167,NA:NA:NA:NA:NA,NA:NA:NA:NA:NA,
ATOSIBAN,Oxytocin receptor antagonist,OXTR,0.8181818181818182,1,"1359,1939,1959,2031,2055,2093,2142,2146,405,439,837","1359,1939,1959,2031,2055,2093,2146,439,837",NA,"48,91","48,91",NA,O: 9 U: 0 A: 11,O: 2 U: 0 A: 2,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,ANTAGONIST,Protein,Membrane receptor,,,CHEMBL382301,NA:NA:NA:NA:NA,NA:NA:NA:NA:NA,
